REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Nugen Bioscience Indonesia (Indonesia)

Main Activities: Other Animal Food Manufacturing
Full name: PT Nugen Bioscience Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Nugen Bioscience Indonesia is an enterprise based in Indonesia. Its main office is in Tangerang. It operates in the Other Animal Food Manufacturing industry. It was first established on January 19, 2004. There was a net sales revenue increase of 19.15% reported in PT Nugen Bioscience Indonesia’s latest financial highlights for 2022. Its’ total assets recorded a growth of 16.28%.

Headquarters
Kota Tangerang Pasir Jaya Jatiuwung Banten
Tangerang; Banten; Postal Code: 15135

Contact Details: Purchase the PT Nugen Bioscience Indonesia report to view the information.

Basic Information
Outstanding Shares:
Purchase the PT Nugen Bioscience Indonesia report to view the information.
Registered Capital:
Purchase the PT Nugen Bioscience Indonesia report to view the information.
Incorporation Date:
January 19, 2004
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Nugen Bioscience Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
19.15%
Total operating revenue
19.15%
Total assets
16.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?